Invest now
Metropolis Healthcare share price
Balanced risk
- ₹567.55(-0.99%)July 21, 2026 09:26:45 AM IST
- NSE
- BSE
- Vol : 1.05 K (NSE + BSE)Last 20 day avg : 358.77 K
Metropolis Healthcare is trading -0.99% lower at Rs 567.55 as compared to its last closing price. Metropolis Healthcare has been trading in the price range of 579.05 & 564.10. Metropolis Healthcare has given 18.98% in this year & 1.60% in the last 5 days. Metropolis Healthcare has TTM P/E ratio 47.30 as compared to the sector P/E of 27.95.There are 18 analysts who have initiated coverage on Metropolis Healthcare. There are 7 analysts who have given it a strong buy rating & 7 analysts have given it a buy rating. 2 analysts have given the stock a sell rating.The company posted a net profit of 50.90 Crores in its last quarter.Listed peers of Metropolis Healthcare include Apollo Hospitals Enterprise (0.11%), Max Healthcare Institute (-0.07%), Fortis Healthcare (0.12%).The Mutual Fund holding in Metropolis Healthcare was at 33.28% in 31 Mar 2026. The MF holding has increased from the last quarter. The FII holding in Metropolis Healthcare was at 10.43% in 31 Mar 2026. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 21 Jul 2026, 09:29 AM IST
- BetaLow volatility0.68Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.15The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.18Annual dividends as a percentage of the stock price.
- PEG RatioIndicates overvaluation6.12The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Metropolis Healthcare News
Metropolis Healthcare Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise | 8,919.50 | 0.11 | 1,28,106.24 | 65.38 | 13.48 | - | - |
| Max Healthcare Institute | 1,101.10 | -0.07 | 1,07,167.14 | 72.01 | 9.94 | - | - |
| Fortis Healthcare | 952.95 | 0.12 | 71,873.34 | 68.65 | 7.35 | - | - |
| Aster DM Healthcare | 818.20 | 0.44 | 42,146.35 | 101.57 | 9.17 | - | - |
| Narayana Hrudayalaya | 2,022.30 | -0.19 | 41,167.06 | 48.19 | 9.11 | - | - |
Mutual Fund Ownership
View allMetropolis Healthcare Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-05-13 | Audited Results & Interim Dividend |
| 2026-02-04 | Quarterly Results & Bonus issue |
| 2025-11-04 | Quarterly Results & Interim Dividend |
| 2025-08-07 | Quarterly Results |
| 2025-05-13 | Audited Results |
About the company Metropolis Healthcare
- IndustryHealthcare Facilities
- ISININE112L01020
- BSE Code542650
- NSE CodeMETROPOLIS
Metropolis Healthcare Limited is engaged in providing diagnostic services to patients, healthcare providers, and corporates across India and Africa. It has a single operating segment, namely Pathology services. It is engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, other pathological and radiological investigations. Its services include Pathology Testing Services, Corporate Wellness, Lab In Hospitals and Clinical Research Services. It serves a diverse customer base, including B2C (Business to Consumer), B2B (Business to Business), and institutional clients. It offers more than 4,000 tests and profiles, including advanced tests for diagnosing cancer, neurological disorders, infectious diseases, and various genetic abnormalities. Its footprint spans 28 states, seven Union Territories.
Metropolis Healthcare Share Price FAQs
Metropolis Healthcare is trading at 567.55 as on Tue Jul 21 2026 03:56:45. This is -0.99% lower as compared to its previous closing price of 547.20.
The market capitalization of Metropolis Healthcare is 11750.30 Cr as on Tue Jul 21 2026 03:56:45.
The average broker rating on Metropolis Healthcare is Buy. The breakup of analyst rating is given below -
- 7 analysts have given a strong buy rating
- 7 analysts have given a buy rating
- 2 analysts have given a hold rating
- 2 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Metropolis Healthcare is 599.90 whereas the 52 wk low is 413.00
Metropolis Healthcare can be analyzed on the following key metrics -
- TTM P/E: 47.30
- Sector P/E: 27.95
- Dividend Yield: 0.17%
- D/E ratio: 0.15
Metropolis Healthcare reported a net profit of 190.02 Cr in 2026.
The Mutual Fund Shareholding was 33.28% at the end of 31 Mar 2026.
Quick Links
EQUITY QUICK LINKS
Metropolis Healthcare QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.